We observed highly significant differences between pathologic MPR and non-MPR tumours (Fig. 3a , Supplementary Data 1.4 ).
← all excerpts
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
1
—
—
We observed highly significant differences between pathologic MPR and non-MPR tumours (Fig. 3a , Supplementary Data 1.4 ).